CTI BioPharma Shares Outstanding 2006-2018 | CTIC

Current and historical number of shares outstanding for CTI BioPharma (CTIC) from 2006 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
CTI BioPharma Annual Shares Outstanding
(Millions of US $)
2017 $36
2016 $28
2015 $19
2014 $15
2013 $11
2012 $6
2011 $3
2010 $2
2009 $2
2008 $0
2007 $0
2006 $0
2005 $0
CTI BioPharma Quarterly Shares Outstanding
(Millions of US $)
Q2 2018 $58
Q1 2018 $50
Q4 2017 $36
Q3 2017 $43
Q2 2017 $32
Q1 2017 $28
Q4 2016 $28
Q3 2016 $28
Q2 2016 $28
Q1 2016 $28
Q4 2015 $19
Q3 2015 $18
Q2 2015 $18
Q1 2015 $17
Q4 2014 $15
Q3 2014 $15
Q2 2014 $14
Q1 2014 $14
Q4 2013 $11
Q3 2013 $11
Q2 2013 $11
Q1 2013 $11
Q4 2012 $6
Q3 2012 $5
Q2 2012 $4
Q1 2012 $4
Q4 2011 $3
Q3 2011 $4
Q2 2011 $3
Q1 2011 $3
Q4 2010 $2
Q3 2010 $2
Q2 2010 $2
Q1 2010 $2
Q4 2009 $2
Q3 2009 $2
Q2 2009 $1
Q1 2009 $1
Q4 2008 $0
Q3 2008 $0
Q2 2008 $0
Q1 2008 $0
Q4 2007 $0
Q3 2007 $0
Q2 2007 $0
Q1 2007 $0
Q4 2006 $0
Q3 2006 $0
Q2 2006 $0
Q1 2006 $0
Q4 2005 $0
Q3 2005 $0
Q2 2005 $0
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.113B $0.025B
CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of therapies covering a spectrum of blood-related cancers. The company is heavily focused on marketing its approved therapy Pixuvri in Europe, and on continuing the development of its late-stage development pipeline, including pacritinib. CTI BioPharma Corp., formerly known as Cell Therapeutics, Inc., is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $51.408B 10.89
Zoetis (ZTS) United States $44.024B 31.95
Grifols (GRFS) Spain $14.128B 18.31
Jazz Pharmaceuticals (JAZZ) Ireland $10.650B 15.67
Neurocrine Biosciences (NBIX) United States $10.514B 0.00
Nektar Therapeutics (NKTR) United States $10.415B 12.18
Sage Therapeutics (SAGE) United States $7.008B 0.00
Ionis Pharmaceuticals (IONS) United States $7.004B 0.00
Catalent (CTLT) United States $5.388B 25.09
United Therapeutics (UTHR) United States $5.372B 6.90
FibroGen (FGEN) United States $5.111B 0.00
Loxo Oncology (LOXO) United States $4.865B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.186B 16.21
Madrigal Pharmaceuticals (MDGL) United States $3.640B 0.00
Endo (ENDP) Ireland $3.605B 5.18
USANA Health Sciences (USNA) United States $3.143B 27.69
Heron Therapeutics (HRTX) United States $3.078B 0.00
Aerie Pharmaceuticals (AERI) United States $2.973B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.887B 0.00
Spectrum Pharmaceuticals (SPPI) United States $2.434B 0.00
Xencor (XNCR) United States $2.289B 0.00
Tilray (TLRY) United States $2.226B 0.00
PTC Therapeutics (PTCT) United States $2.097B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.917B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.744B 21.32
Zogenix (ZGNX) United States $1.741B 0.00
Portola Pharmaceuticals (PTLA) United States $1.733B 0.00
Impax Laboratories (AMRX) United States $1.636B 35.16
TESARO (TSRO) United States $1.540B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.515B 0.00
Corcept Therapeutics (CORT) United States $1.447B 22.27
Arrowhead Pharmaceuticals (ARWR) United States $1.439B 0.00
ImmunoGen (IMGN) United States $1.374B 0.00
TherapeuticsMD (TXMD) United States $1.271B 0.00
Esperion Therapeutics (ESPR) United States $1.262B 0.00
Endocyte (ECYT) United States $1.145B 0.00
Karyopharm Therapeutics (KPTI) United States $1.121B 0.00
Tricida (TCDA) United States $1.001B 0.00
Radius Health (RDUS) United States $0.963B 0.00
Flexion Therapeutics (FLXN) United States $0.863B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.770B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.705B 0.00
CASI Pharmaceuticals (CASI) United States $0.680B 0.00
ArQule (ARQL) United States $0.655B 0.00
GlycoMimetics (GLYC) United States $0.644B 0.00
Siga Technologies (SIGA) United States $0.644B 0.00
Dova Pharmaceuticals (DOVA) United States $0.641B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.591B 0.00
Collegium Pharmaceutical (COLL) United States $0.574B 0.00
ChemoCentryx (CCXI) United States $0.555B 33.21
OptiNose (OPTN) United States $0.526B 0.00
Lannett Co Inc (LCI) United States $0.515B 4.74
Odonate Therapeutics (ODT) United States $0.510B 0.00
Majesco Entertainment (COOL) United States $0.508B 0.00
Aclaris Therapeutics (ACRS) United States $0.504B 0.00
Xeris Pharmaceuticals (XERS) United States $0.494B 0.00
Translate Bio (TBIO) United States $0.476B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.459B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.448B 0.00
Akebia Therapeutics (AKBA) United States $0.447B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.439B 0.00
Forty Seven (FTSV) United States $0.434B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.416B 0.00
Dermira (DERM) United States $0.407B 0.00
Aquestive Therapeutics (AQST) United States $0.405B 0.00
Concert Pharmaceuticals (CNCE) United States $0.392B 0.00
ElectroCore (ECOR) United States $0.387B 0.00
Mast Therapeutics (SVRA) United States $0.371B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.364B 24.86
Neon Therapeutics (NTGN) United States $0.338B 0.00
Minerva Neurosciences (NERV) United States $0.326B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.297B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.277B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.277B 0.00
Opexa Therapeutics (ACER) United States $0.270B 0.00
Zafgen (ZFGN) United States $0.264B 0.00
Achaogen (AKAO) United States $0.255B 0.00
Jounce Therapeutics (JNCE) United States $0.247B 0.00
Aratana Therapeutics (PETX) United States $0.245B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.243B 0.00
Ocular Therapeutix (OCUL) United States $0.242B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.236B 0.00
Tyme Technologies (TYME) United States $0.232B 0.00
IMV INC (IMV) Canada $0.226B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.222B 0.00
DURECT (DRRX) United States $0.212B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.203B 0.00
Adherex Technologies (FENC) United States $0.196B 0.00
Ardelyx (ARDX) United States $0.195B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.185B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.185B 0.00
MediWound (MDWD) Israel $0.179B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.178B 0.00
Neos Therapeutics (NEOS) United States $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 0.00
Calithera Biosciences (CALA) United States $0.171B 0.00
Cardiome Pharma (CORV) Canada $0.168B 0.00
Galectin Therapeutics (GALT) United States $0.167B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.164B 0.00
Immune Design (IMDZ) United States $0.164B 0.00
ContraFect (CFRX) United States $0.160B 0.00
Aldeyra Therapeutics (ALDX) United States $0.158B 0.00
Melinta Therapeutics (MLNT) United States $0.147B 0.00
ProNAi Therapeutics (SRRA) Canada $0.145B 0.00
Molecular Templates (MTEM) United States $0.141B 0.00
KalVista Pharmaceuticals (KALV) United States $0.141B 0.00
Forward Pharma (FWP) Denmark $0.136B 0.00
MEI Pharma (MEIP) United States $0.135B 0.00
Redhill Biopharma (RDHL) Israel $0.128B 0.00
SteadyMed (STDY) Israel $0.126B 0.00
Recro Pharma (REPH) United States $0.123B 0.00
Iterum Therapeutics (ITRM) Ireland $0.120B 0.00
Infinity Pharmaceuticals (INFI) United States $0.118B 0.00
Rafael Holdings (RFL) United States $0.113B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.112B 0.00
Otonomy (OTIC) United States $0.098B 0.00
BioLineRx (BLRX) Israel $0.095B 0.00
Nivalis Therapeutics (ALPN) United States $0.095B 0.00
Affimed (AFMD) Germany $0.090B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 0.00
Champions Oncology (CSBR) United States $0.086B 0.00
Natural Alternatives (NAII) United States $0.074B 9.51
KemPharm (KMPH) United States $0.073B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.071B 0.00
Trillium Therapeutics (TRIL) Canada $0.069B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.068B 0.00
Novan (NOVN) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.063B 0.00
Genocea Biosciences (GNCA) United States $0.054B 0.00
Capnia (SLNO) United States $0.053B 0.00
Mannatechorporated (MTEX) United States $0.050B 26.33
Tokai Pharmaceuticals (NVUS) United States $0.049B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.045B 37.67
Heat Biologics (HTBX) United States $0.042B 0.00
Avenue Therapeutics (ATXI) United States $0.039B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.038B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.92
Matinas Biopharma Holdings (MTNB) United States $0.034B 0.00
Biomerica (BMRA) United States $0.033B 0.00
Xenetic Biosciences (XBIO) United States $0.033B 0.00
IsoRay (ISR) United States $0.032B 0.00
Lipocine (LPCN) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.031B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.031B 0.00
Onconova Therapeutics (ONTX) United States $0.031B 0.00
HANCOCK JAFFE (HJLI) United States $0.029B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.029B 0.00
Regulus Therapeutics (RGLS) United States $0.028B 0.00
Shineco (TYHT) China $0.025B 2.15
XTL Biopharmaceuticals (XTLB) Israel $0.024B 0.00
NanoViricides (NNVC) United States $0.024B 0.00
Can-Fite Biopharma (CANF) Israel $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
Aradigm (ARDM) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
ESSA Pharma (EPIX) Canada $0.018B 0.00
Midatech Pharma (MTP) United Kingdom $0.017B 0.00
Egalet (EGLT) United States $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Skyline Medical (AIPT) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
PharmAthene (ALT) United States $0.013B 0.00
India Globalization Capital (IGC) United States $0.012B 0.00
Intellipharmaceutics (IPCI) Canada $0.012B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.010B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.008B 0.00
Pain Therapeutics (PTIE) United States $0.008B 0.00
RXi Pharmaceuticals (RXII) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.006B 0.00
Biostar Pharmaceuticals (BSPM) China $0.005B 2.86
Aralez Pharmaceuticals (ARLZ) Canada $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00